Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 834-841

  Johnson, Christopher ^a   Ahsan, Nasimul ^c   Gonwa, Thomas ^c   Halloran, Philip ^c   Stegall, Mark ^b   Hardy, Mark ^c   Metzger, Robert ^c   Shield III, Charles ^c   Rocher, Leslie ^c   Scandling, John ^c   Sorensen, John ^c   Mulloy, Laura ^c   Light, Jimmy ^c   Corwin, Claudia ^c   Danovitch, Gabriel ^c   Wachs, Michael ^c   VanVeldhuisen, Paul ^c   Salm, Kim ^c   Tolzman, Diane ^c   Fitzsimmons, William E ^c  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREMOR;

EID: 0034654005     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00028     Document Type: Article

References (17)

1. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977.
2. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436.
3. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
4. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995; 1: 1321.
5. H. W. Sollinger for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejectionin primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
6. Mendez R, for the FK506 MMF Dose-Ranging Kidney Transplant Study Group. FK506 and mycophenolate mofetil in renal transplant recipients: Six-month results of a multicenter, randomized dose ranging trial. Transplant Proc 1998; 30: 1287.
7. Vanrenterghem V, Squifflet JP, Forsythe J, et al. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. Transplant Proc 1998; 30: 1290.
8. Ochiai T, Gunji Y, Nagato M, Asano P, Isono K. Effective and safe use of FK506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation. Transplant Proc 1991; 23: 2718.
9. Murase N, Starzl TE, Demetris J, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701.
10. Tanabe M, Todo S, Murase N, et al. Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. Transplantation 1994; 58: 23.
11. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol 1998; 160: 1982
12. Yang HC, Holman MJ, Langhoff E, et al. Tacrolimus/low-dose mycophenolate mofetil versus microemulsion cyclosporine/low-dose mycophenolate mofetil after kidney transplantation - 1 year follow-up of a prospective, randomized clinical trial. Transplant Proc 1999; 31: 1121
13. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999; 67: 411
14. Shah MB, Martin JE, Schroeder TJ, First MR. The evaluation of the safety and tolerability of two formulations of cyclosporine: Neoral and Sandimmune. Transplantation 1999; 11: 1411.
15. Pelletier RP, Cosio FG, Henry ML, et al. Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time. Clin Transplant 1998; 12: 543.
16. Hansen HE, Olsen S, Madsen M. Renal allograft survival related to the severity of acute rejection graded according to the Banff schema. J Am Soc Nephrol 1997; 8: 684a.
17. Neylan JF, Sullivan EM, Steinwald B, Goss TF. Assessment of the frequency and costs of post transplantation hospitalizations in patients receiving tacrolimus versus cyclosporine. Am J Kid Dis 1998; 32: 770.